3 min read
The Psychedelic Setback: What MDMA Rejection Taught Drug Developers
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...
Meet Veristat at the Outsourcing in Clinical Trials Europe 2022 ( OCT) taking place on the 4th -5th May 2022, Booth #29
With more than 27 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.
Whether you have a compound and need to get started on your IND, or want to recruit patients quickly to get your early phase trials running or just need medical writing or biostatistical support for your programs - Veristat can help.
We provide impactful drug development and regulatory solutions on both a full-service or functional service basis.
Schedule A Meeting
Schedule a meeting by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes.
Conference Details
Website: https://www.arena-international.com/octeurope/